Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Digital content

02 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/02/3247237/0/en/MapLight-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

09 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/09/3215999/0/en/MapLight-Therapeutics-Updates-Expected-Timing-of-Topline-Results-for-Ongoing-Phase-2-Studies-to-Q3-2026.html

05 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/05/3212597/0/en/MapLight-Therapeutics-Receives-Fast-Track-Designation-for-ML-007C-MA-for-Alzheimer-s-Disease-Psychosis.html

16 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/16/3206094/0/en/SandboxAQ-and-MapLight-Therapeutics-Announce-Strategic-Collaboration-to-Discover-and-Develop-Novel-CNS-Therapies.html

04 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/04/3199651/0/en/MapLight-Therapeutics-Reports-Third-Quarter-Financial-Results-and-Highlights-Corporate-Progress.html

29 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/29/3176533/0/en/MapLight-Therapeutics-Announces-Closing-of-Initial-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
ABOUT THIS PAGE